StatLab Medical Products Acquires Pyramid Innovation

Leica Biosystems to Acquire StatLab Medical Products From Linden Capital Partners and Audax Private Equity

July 14, 2026

Medical Devices

Leica Biosystems, a Danaher company, signed a definitive agreement to acquire StatLab Medical Products. StatLab is currently owned by Linden Capital Partners and Audax Private Equity, and the transaction is subject to customary closing conditions. Financial terms were not disclosed and the deal was expected to close by the end of 2026.

StatLab Medical Products Acquires Scientific Device Laboratory

April 25, 2024

Medical Devices

StatLab Medical Products, a McKinney, Texas-based manufacturer of medical diagnostic supplies, has acquired Scientific Device Laboratory (SDL), a Chicago-area maker of printed diagnostic slides and consumables for anatomic pathology and microbiology. The acquisition expands StatLab's microbiology capabilities, adds a U.S. R&D/manufacturing hub, and creates a dual-continent footprint for glass-slide manufacturing to better serve hospital, OEM and research customers.

StatLab Medical Products Acquires Poly Scientific R&D

March 26, 2024

Medical Devices

StatLab Medical Products has acquired Poly Scientific R&D, a Bay Shore, New York-based manufacturer of pathology stains, reagents and tissue controls. The deal adds tissue control slide manufacturing and other anatomic pathology consumables to StatLab’s portfolio, expanding its manufacturing capabilities and market presence.

Audax Private Equity Makes Growth Investment in Pyramid Laboratories, Inc.

April 18, 2023

Pharmaceuticals

Audax Private Equity has made a growth investment in Pyramid Laboratories, Inc., a Costa Mesa, California-based CDMO that provides formulation development, analytical/stability testing, and aseptic fill-finish manufacturing for large-molecule biologics. The capital will support planned facility expansions to increase vial-filling capacity by more than 30% and syringe filling by more than 50%, and to scale Pyramid's clinical and commercial biologics manufacturing and service operations.

StatLab Medical Products Acquires CellPath Ltd.

June 8, 2022

Medical Devices

StatLab Medical Products, a portfolio company of Audax Private Equity and Linden Capital Partners, acquired UK-based CellPath Ltd., a manufacturer and supplier focused on the histology and cytology markets. The deal adds injection-molding manufacturing capabilities, proprietary products (including the CellNass archiving service), and an established European customer base to support StatLab's international growth.

Audax Private Equity and Linden Capital Partners Acquire StatLab Medical Products

January 12, 2021

Medical Devices

Audax Private Equity and Linden Capital Partners have acquired StatLab Medical Products, a McKinney, Texas-based manufacturer and distributor of histology, cytology and immunohistochemistry consumables, reagents, and equipment. The deal — a purchase from Cressey & Company LP — positions StatLab for accelerated organic growth and buy-and-build activity to expand its product suite and customer base.